Glenmark receives approval to market Momate Rhino metered nasal spray in Russia

Glenmark Pharmaceuticals announced that it has received approval from the Ministry of Healthcare, Russia to market Momate Rhino (Mometasone Furoate 50 mcg) metered nasal spray as an over]the]counter (OTC) product for the treatment of seasonal and perennial allergic rhinitis in patients above 18 years of age.

Powered by Capital Market - Live News